These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3016001)

  • 1. Isolation of high-specific-activity subunits of cholera toxin by reversed-phase high-performance liquid chromatography.
    Pearson SD; Dixon JD; Nothwehr SF; Kurosky A
    J Chromatogr; 1986 May; 359():413-21. PubMed ID: 3016001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside.
    Tayot JL; Holmgren J; Svennerholm L; Lindblad M; Tardy M
    Eur J Biochem; 1981 Jan; 113(2):249-58. PubMed ID: 6258916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of preformed cholera toxin-ganglioside GM1 complex.
    Fiani ML; Macioce P; Gallina A; Tomasi M
    J Neurosci Res; 1984; 12(2-3):325-34. PubMed ID: 6094837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cautionary note on the use of the B subunit of cholera toxin as a ganglioside GM1 probe: detection of cholera toxin A subunit in B subunit preparations by a sensitive adenylate cyclase assay.
    Spiegel S
    J Cell Biochem; 1990 Mar; 42(3):143-52. PubMed ID: 2156874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomeric structure of cholera toxin: characteristics of the H and L subunits.
    Holmgren J; Lonnroth I
    J Gen Microbiol; 1975 Jan; 86(1):49-65. PubMed ID: 803547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ADP-ribosyltransferase activity of cholera toxin by MDL 12330A and chlorpromazine.
    Bitonti AJ
    Biochem Biophys Res Commun; 1984 Apr; 120(2):700-6. PubMed ID: 6329180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the cholera toxin receptor on Balb/c 3T3 cells as a ganglioside similar to, or identical with, ganglioside GM1. No evidence for galactoproteins with receptor activity.
    Critchley DR; Streuli CH; Kellie S; Ansell S; Patel B
    Biochem J; 1982 Apr; 204(1):209-19. PubMed ID: 7052064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 3-dependent mouse mast cells express the cholera toxin-binding acidic glycosphingolipid, ganglioside GM1, and increase their histamine content in response to toxin.
    Katz HR; Levine JS; Austen KF
    J Immunol; 1987 Sep; 139(5):1640-6. PubMed ID: 2957431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, function, and antigenicity of cholera toxin.
    Markel DE; Hejtmancik KE; Peterson JW; Kurosky A
    J Supramol Struct; 1979; 10(2):137-49. PubMed ID: 88548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of cholera toxin by affinity chromatography on porous silica beads with covalently coupled ganglioside GM1.
    Tayot JL; Tardy M
    Adv Exp Med Biol; 1980; 125():471-8. PubMed ID: 6153858
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholera toxin B subunit-binding and ganglioside GM1 immuno-expression are not necessarily correlated in human salivary glands.
    Kirkeby S
    Acta Odontol Scand; 2014 Nov; 72(8):694-700. PubMed ID: 24655314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of biological activity due to Glu-->Arg mutation at residue 11 of the B subunit of cholera toxin.
    Yamaoka J; Yamasaki S; Kurazono H; Imamura S; Noda M; Miyai K; Takeda Y
    Microb Pathog; 1997 Nov; 23(5):297-302. PubMed ID: 9405207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymic activity of cholera toxin. II. Relationships to proteolytic processing, disulfide bond reduction, and subunit composition.
    Mekalanos JJ; Collier RJ; Romig WR
    J Biol Chem; 1979 Jul; 254(13):5855-61. PubMed ID: 221485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of mono ADP-ribosyltransferase activity by using guanylhydrazones.
    Soman G; Tomer KB; Graves DJ
    Anal Biochem; 1983 Oct; 134(1):101-10. PubMed ID: 6318594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational changes in subunit A of cholera toxin following the binding of ganglioside to subunit B.
    van Heyningen SU
    Eur J Biochem; 1982 Feb; 122(2):333-7. PubMed ID: 7060580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of a dinucleotide fold in cholera toxin: possible approach to chemoprophylaxis?
    Dorai DT
    Biosci Rep; 1983 Sep; 3(9):879-86. PubMed ID: 6315104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1.
    Schön A; Freire E
    Biochemistry; 1989 Jun; 28(12):5019-24. PubMed ID: 2765522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholera toxin-B subunit blocks excitatory effects of opioids on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions.
    Shen KF; Crain SM
    Brain Res; 1990 Oct; 531(1-2):1-7. PubMed ID: 1981160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP-independent effects of cholera toxin on B cell activation. III. Cholera toxin A subunit-mediated ADP-ribosylation acts synergistically with ionomycin or IL-4 to induce B cell proliferation.
    Francis ML; Okazaki I; Moss J; Kurosky A; Pecanha LM; Mond JJ
    J Immunol; 1995 May; 154(10):4956-64. PubMed ID: 7730606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity purification of recombinant cholera toxin B subunit oligomer expressed in Bacillus brevis for potential human use as a mucosal adjuvant.
    Yasuda Y; Matano K; Asai T; Tochikubo K
    FEMS Immunol Med Microbiol; 1998 Apr; 20(4):311-8. PubMed ID: 9626936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.